Higher High-Mobility Group Box-1 Levels are Associated with White Matter Lesions in Ischemic Stroke Patients

References

• de Leeuw F, de Groot J, Achten E, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry. 2001;70(1):9–14. doi:10.1136/jnnp.70.1.9
   PubMed Web of Science ®Google Scholar
• Honda Y, Noguchi A, Maruyama K, et al. Volumetric analyses of cerebral white matter hyperintensity lesions on magnetic resonance imaging in a Japanese population undergoing medical check-up. Geriatr Gerontol Int. 2015;15:43–47. doi:10.1111/ggi.12672
   PubMed Web of Science ®Google Scholar
• Hilal S, Mok V, Youn Y, Wong A, Ikram M, Chen C. Prevalence, risk factors and consequences of cerebral small vessel diseases: data from three Asian countries. J Neurol Neurosurg Psychiatry. 2017;88(8):669–674. doi:10.1136/jnnp-2016-315324
   PubMed Web of Science ®Google Scholar
• Rudilosso S, Rodríguez-Vázquez A, Urra X, Arboix A. The potential impact of neuroimaging and translational research on the clinical management of lacunar stroke. Int J Mol Sci. 2022;23(3):1497. doi:10.3390/ijms23031497
   PubMed Web of Science ®Google Scholar
• Bos D, Wolters F, Darweesh S, et al. Cerebral small vessel disease and the risk of dementia: a systematic review and meta-analysis of population-based evidence. Alzheimers Dement. 2018;14(11):1482–1492. doi:10.1016/j.jalz.2018.04.007
   PubMed Web of Science ®Google Scholar
• Charidimou A, Pasi M, Fiorelli M, et al. Leukoaraiosis, cerebral hemorrhage, and outcome after intravenous thrombolysis for acute ischemic stroke: a meta-analysis (v1). Stroke. 2016;47(9):2364–2372. doi:10.1161/STROKEAHA.116.014096
   PubMed Web of Science ®Google Scholar
• Zhang X, Tang Y, Xie Y, et al. Total magnetic resonance imaging burden of cerebral small-vessel disease is associated with post-stroke depression in patients with acute lacunar stroke. Eur J Neurol. 2017;24(2):374–380. doi:10.1111/ene.13213
   PubMed Web of Science ®Google Scholar
• Henninger N, Lin E, Haussen D, et al. Leukoaraiosis and sex predict the hyperacute ischemic core volume. Stroke. 2013;44(1):61–67. doi:10.1161/STROKEAHA.112.679084
   PubMed Web of Science ®Google Scholar
• Giurgiutiu D, Yoo A, Fitzpatrick K, et al. Severity of leukoaraiosis, leptomeningeal collaterals, and clinical outcomes after intra-arterial therapy in patients with acute ischemic stroke. J Neurointerv Surg. 2015;7(5):326–330. doi:10.1136/neurintsurg-2013-011083
   PubMed Web of Science ®Google Scholar
• Wang H, Bloom O, Zhang M, et al. HMGB-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285(5425):248–251. doi:10.1126/science.285.5425.248
   PubMed Web of Science ®Google Scholar
• Fonken L, Frank M, Kitt M, et al. The Alarmin HMGB1 mediates age-induced neuroinflammatory priming. J Neurosci. 2016;36(30):7946–7956. doi:10.1523/JNEUROSCI.1161-16.2016
   PubMed Web of Science ®Google Scholar
• Lu B, Wang C, Wang M, et al. Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review. Expert Rev Clin Immunol. 2014;10(6):713–727. doi:10.1586/1744666X.2014.909730
   PubMed Web of Science ®Google Scholar
• Agnello D, Wang H, Yang H, Tracey K, Ghezzi P. HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine. 2002;18(4):231–236. doi:10.1006/cyto.2002.0890
   PubMed Web of Science ®Google Scholar
• Zhang J, Takahashi H, Liu K, et al. Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke. 2011;42(5):1420–1428. doi:10.1161/STROKEAHA.110.598334
   PubMed Web of Science ®Google Scholar
• Tsukagawa T, Katsumata R, Fujita M, et al. Elevated serum high-mobility group box-1 protein level is associated with poor functional outcome in ischemic stroke. J Stroke Cerebrovasc Dis. 2017;26(10):2404–2411. doi:10.1016/j.jstrokecerebrovasdis.2017.05.033
   PubMed Web of Science ®Google Scholar
• Ved R, Manivannan S, Tasker I, Zaben M. High mobility group box protein 1 and white matter injury following traumatic brain injury: perspectives on mechanisms and therapeutic strategies. Neural Regen Res. 2022;17(8):1739–1740. doi:10.4103/1673-5374.332135
   PubMed Web of Science ®Google Scholar
• Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO task force on stroke and other cerebrovascular disorders. Stroke. 1989;20(10):1407–1431. doi:10.1161/01.STR.20.10.1407
   PubMed Web of Science ®Google Scholar
• Sucharew H, Khoury J, Moomaw C, et al. Profiles of the national institutes of health stroke scale items as a predictor of patient outcome. Stroke. 2013;44(8):2182–2187. doi:10.1161/STROKEAHA.113.001255
   PubMed Web of Science ®Google Scholar
• Adams HJ, Bendixen B, Kappelle L, Biller J, Love B, Gordon D. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke. 1993;24(1):35–41. doi:10.1161/01.STR.24.1.35
   PubMed Web of Science ®Google Scholar
• Wardlaw J, Smith E, Biessels G, et al. STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(2):822–838. doi:10.1016/S1474-4422(13)70124-8
   PubMedGoogle Scholar
• Helenius J, Henninger N. Leukoaraiosis burden significantly modulates the association between infarct volume and national institutes of health stroke scale in ischemic stroke. Stroke. 2015;46(7):1857–1863. doi:10.1161/STROKEAHA.115.009258
   PubMed Web of Science ®Google Scholar
• Fazekas F, Niederkorn K, Schmidt R, et al. White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke. 1988;19(10):1285–1288. doi:10.1161/01.STR.19.10.1285
   PubMed Web of Science ®Google Scholar
• Xie Y, Zhuo X, Xing K, et al. Circulating lipocalin-2 as a novel biomarker for early neurological deterioration and unfavorable prognosis after acute ischemic stroke. Brain Behav. 2023;13(5):e2979. doi:10.1002/brb3.2979
   PubMedGoogle Scholar
• Patti J, Helenius J, Puri A, Henninger N. White matter hyperintensity-adjusted critical infarct thresholds to predict a favorable 90-day outcome. Stroke. 2016;47(10):2526–2533. doi:10.1161/STROKEAHA.116.013982
   PubMed Web of Science ®Google Scholar
• Sun L, Hui L, Li Y, Chen X, Liu R, Ma J. Pathogenesis and research progress in leukoaraiosis. Front Hum Neurosci. 2022;16:902731. doi:10.3389/fnhum.2022.902731
   PubMed Web of Science ®Google Scholar
• Grau-Olivares M, Arboix A. Mild cognitive impairment in stroke patients with ischemic cerebral small-vessel disease: a forerunner of vascular dementia? Expert Rev Neurother. 2009;9(8):1201–1217. doi:10.1586/ern.09.73
   PubMed Web of Science ®Google Scholar
• Shi G, Ke D, Gong P, et al. Serum YKL-40 levels and white matter hyperintensities in patients with acute ischemic stroke. J Inflamm Res. 2023;16:311–319. doi:10.2147/JIR.S398701
   PubMed Web of Science ®Google Scholar
• Suda S, Kanamaru T, Okubo S, et al. Urinary albumin-to-creatinine ratio is associated with white matter lesions severity in first-ever stroke patients. J Neurol Sci. 2017;373:258–262. doi:10.1016/j.jns.2017.01.011
   PubMed Web of Science ®Google Scholar
• Shan W, Xu L, Qiu Z, et al. Increased high-mobility group box 1 levels are associated with depression after acute ischemic stroke. Neurol Sci. 2022;43(5):3131–3137. doi:10.1007/s10072-021-05571-x
   PubMed Web of Science ®Google Scholar
• Gao Y, Li D, Lin J, et al. Cerebral small vessel disease: pathological mechanisms and potential therapeutic targets. Front Aging Neurosci. 2022;14:961661. doi:10.3389/fnagi.2022.961661
   PubMed Web of Science ®Google Scholar
• Nishibori M, Wang D, Ousaka D, Wake H. High mobility group box-1 and blood-brain barrier disruption. Cells. 2020;9(12):2650. doi:10.3390/cells9122650
   PubMed Web of Science ®Google Scholar
• Zupan M, Šabović M, Zaletel M, Popovič K, Žvan B. The presence of cerebral and/or systemic endothelial dysfunction in patients with leukoaraiosis--a case control pilot study. BMC Neurol. 2015;15:158. doi:10.1186/s12883-015-0416-z
   PubMed Web of Science ®Google Scholar
• Choi J, Jin X, Kim H, Koh S, Cho H, Kim B. High mobility group box 1 as an autocrine chemoattractant for oligodendrocyte lineage cells in white matter stroke. Stroke. 2023;54(2):575–586. doi:10.1161/STROKEAHA.122.041414
   PubMed Web of Science ®Google Scholar
• Tang D, Kang R, Zeh HJ, Lotze MT. High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal. 2011;14(7):1315–1335. doi:10.1089/ars.2010.3356
   PubMed Web of Science ®Google Scholar
• Huo X, Su B, Qin G, Zhao L. HMGB1 promotes Ox-LDL-induced endothelial cell damage by inhibiting PI3K/Akt signaling pathway. BMC Cardiovasc Disord. 2022;22(1):555. doi:10.1186/s12872-022-03003-y
   PubMed Web of Science ®Google Scholar
• Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43(9):1683–1689. doi:10.1212/WNL.43.9.1683
   PubMed Web of Science ®Google Scholar
• Simpson J, Ince P, Higham C, et al. Microglial activation in white matter lesions and nonlesional white matter of ageing brains. Neuropathol Appl Neurobiol. 2007;33(6):670–683. doi:10.1111/j.1365-2990.2007.00890.x
   PubMed Web of Science ®Google Scholar
• Fernando M, Simpson J, Matthews F, et al.; MRC Cognitive Function and Ageing Neuropathology Study Group. White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke. 2006;37(6):1391–1398. doi:10.1161/01.STR.0000221308.94473.14
   PubMed Web of Science ®Google Scholar
• Valdés Hernández Mdel C, Morris Z, Dickie D, et al. Close correlation between quantitative and qualitative assessments of white matter lesions. Neuroepidemiology. 2013;40(1):13–22. doi:10.1159/000341859
   PubMed Web of Science ®Google Scholar
• Kim G, Park K, Avery R, et al. Extensive leukoaraiosis is associated with high early risk of recurrence after ischemic stroke. Stroke. 2014;45(2):479–485. doi:10.1161/STROKEAHA.113.003004
   PubMed Web of Science ®Google Scholar